Tag: pharmaceuticals
-
Trial Shows Broad Coronavirus Immune Response
Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses.
-
Small Biz Award Funds Wearable Drug Delivery Patch
A developer of medical devices designed as skin patches received a contract to develop a device to deliver any drug approved by FDA for delivery through the skin.
-
Infographic – Deaths From Nipah Virus
Nipah virus is a rare but deadly infectious disease affecting south and southeast Asia, and since August the Kerala state in India recorded six Nipah cases leading to two deaths.
-
FDA Clears Biotech Seasonal Flu Treatment Trial
A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains.
-
Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.
-
University Start-Up Developing Inhaled Gene Therapies
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases.
-
Small Biz Grant Supports Regenerative Alzheimer’s Treatment
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease.
-
Autoimmune Neuro Disease Start-Up Raises $58M
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
-
Infographic – HIV Infections Fall in Africa. Rise in Mideast, Europe
The number of new infections from the human immunodeficiency virus or HIV declined worldwide last year and over the past decade, with the sharpest declines in sub-Saharan Africa.
-
Venture Firm, Cancer Center Start Antibody Biotech Company
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets.